Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Perianal Crohns Disease Clinical Trials

100 recruiting trials for Perianal Crohns Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
11
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07033208

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

The goal of this research is to learn how a new device called the wireless thermal capsule (WTC) can collect thermal data to help see diseases that happen in the gastrointestinal...

Sponsor: Massachusetts General HospitalEnrolling: 101 location
RECRUITINGNCT07077681

Evaluation of the Acceptability and Therapeutic Maintenance After Substitution of Ustekinumab With a Biosimilar

In a population of adult patients followed for Crohn's disease, who had previously agreed to replace Stelara® with a biosimilar of ustekinumab (Uzpruvo®) and were followed over a...

Sponsor: EG LaboEnrolling: 24611 locations
RECRUITINGNCT04178408

IBD Registry in a Sub-Saharan African Population

The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will...

Sponsor: University of ZimbabweEnrolling: 1001 location
RECRUITINGNCT06553053

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

The aim of this study was to further improve the clinical efficacy of acupuncture in delaying the clinical recurrence of CD and to explore the efficacy mechanism of acupuncture...

Sponsor: Shanghai Institute of Acupuncture, Moxibustion and MeridianEnrolling: 1061 location
RECRUITINGNCT06997055

ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar

ROLL'YN-UST is a real-life study, which includes patients in clinical remission for at least 3 months and who have been treated with a reference biotherapy for at least 6 months,...

Sponsor: Celltrion HealthCare FranceEnrolling: 2251 location
RECRUITINGNCT06856044

Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy

60% of patients with Crohn's disease will undergo surgery during their lifetime and without recurrence prevention treatment, 80% of patients will have an endoscopic recurrence...

Sponsor: Centre Hospitalier Universitaire de NīmesEnrolling: 302 locations
RECRUITINGNCT06216899

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

This study will compare the tolerability and efficacy of conventional formula Exclusive Enteral Nutrition (EEN) and whole-food blended smoothie EEN by enrolling a total of 60...

Sponsor: Seattle Children's HospitalEnrolling: 603 locations
RECRUITINGNCT07191106

Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in...

Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although...

Sponsor: Raincy Montfermeil Hospital GroupEnrolling: 722 locations
RECRUITINGNCT06094608

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.

Sponsor: University of MichiganEnrolling: 681 location
RECRUITINGNCT05414578

NORDTREAT Prospective Study on Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), primarily ulcerative colitis (UC) and Crohn's disease (CD), is a chronic disease entity affecting individuals of all ages, and which may severely...

Sponsor: University of Southern DenmarkEnrolling: 80017 locations
RECRUITINGNCT06805890

Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology

Inflammatory Bowel Diseases (IBD) are chronic inflammations of the gastrointestinal tract. Regardless of the etiology, a common trait of IBD pathogenesis is the inflammatory...

Sponsor: Assistance Publique Hopitaux De MarseilleEnrolling: 601 location
RECRUITINGPhase 1 / Phase 2NCT03847467

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF...

Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1163 locations
RECRUITINGPhase 1 / Phase 2NCT00692939

Autologous Stem Cell Transplantation for Crohn's Disease

The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood...

Sponsor: Paul SzabolcsEnrolling: 202 locations
RECRUITINGPhase 2NCT06226883

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study...

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Enrolling: 38520 locations
RECRUITINGNCT04191395

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points....

Sponsor: Centre Hospitalier Universitaire de BesanconEnrolling: 30001 location
RECRUITINGNCT06581042

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease...

Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. Ulcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting...

Sponsor: AbbVieEnrolling: 2807 locations
RECRUITINGNCT06533228

Helmsley 3.0: Abbreviated MRE

The purpose of our study is to compare an abbreviated magnetic resonance imaging (MRI) of the bowel or magnetic resonance enterography (MRE) protocol to a conventional, standard...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 3002 locations
RECRUITINGNCT07421258

A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease...

Inflammatory Bowel Disease (IBD), encompassing Crohn's Disease (CD) and Ulcerative Colitis (UC), is a chronic, relapsing, and often disabling condition characterized by...

Sponsor: AbbVieEnrolling: 20004 locations
RECRUITINGNCT04803916

Pre-stenotic Inflammation Following Endoscopic Balloon Dilatation in Crohn's Disease: A Prospective Study

As a consequence of chronic relapsing inflammation in Crohn's disease (CD), progressive bowel damage and scarring occurs in affected regions of intestine. This damage often leads...

Sponsor: Shaare Zedek Medical CenterEnrolling: 241 location
RECRUITINGNCT06756100

Early Inflammatory Bowel Disease Progression

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 1401 location
RECRUITINGNCT07504510

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

The goal of this observational study is to evaluate the effectiveness and safety of exclusive enteral nutrition (EEN) in adults with active Crohn's disease (CD), particularly in...

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen UniversityEnrolling: 3001 location
RECRUITINGNCT07219537

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

The investigators have developed an inexpensive tool to take pictures in the lower GI tract without sedation and to look for signs of disease. The tool is a capsule, about the...

Sponsor: Massachusetts General HospitalEnrolling: 301 location
RECRUITINGNCT06698601

Wild Blueberries in Colitis

The goal of this exploratory, prospective, monocentric randomized crossover study is to investigate the influence of a blueberry-rich diet compared to a blueberry-poor diet on the...

Sponsor: Universität Duisburg-EssenEnrolling: 601 location
RECRUITINGNCT06882993

Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose Crohn's disease instead of colonoscopy and a small bowel...

Sponsor: Esbjerg Hospital - University Hospital of Southern DenmarkEnrolling: 1655 locations
RECRUITINGNCT04912999

Inflammatory Bowel Diseases Remission Registry

The inflammatory bowel diseases (IBDs), ulcerative colitis (UC) and Crohn's disease (CD), are characterized by lifelong relapsing-remitting gastrointestinal inflammation, with...

Sponsor: Tel-Aviv Sourasky Medical CenterEnrolling: 10001 location
RECRUITINGPhase 3NCT06227910

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the...

Sponsor: TakedaEnrolling: 39620 locations
RECRUITINGPhase 4NCT06113913

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

The goal of this clinical trial is to learn about the treatment with subcutaneous infliximab in patients with inflammatory bowel disease (IBD) that were previously treated with an...

Sponsor: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZWEnrolling: 27515 locations
RECRUITINGPhase 4NCT05781152

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with...

Sponsor: Connecticut Children's Medical CenterEnrolling: 90020 locations
RECRUITINGNCT05579392

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis

Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the most significant chronic conditions of the...

Sponsor: Rush University Medical CenterEnrolling: 302 locations
RECRUITINGNCT06647615

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain...

The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite lack of evidence of...

Sponsor: Mayo ClinicEnrolling: 151 location
RECRUITINGNCT07013578

TIDHI Mental Health in IBD Patients Study

The purpose of this study is to test the impact of Healing Circuits™; a structured mental health support model on IBD patients. The eligible study participants will be randomly...

Sponsor: TIDHI Innovation Inc.Enrolling: 1001 location
RECRUITINGNCT07132333

Molecular Inflammation Board at the Center for Personalized Medicine

Molecular Inflammation Board at the Center for Personalized Medicine

Sponsor: University Hospital TuebingenEnrolling: 30001 location
RECRUITINGPhase 3NCT04779320

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be...

Sponsor: TakedaEnrolling: 12020 locations
RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT04960826

Study of an Environmental Risk Factor in Crohn's Disease

Inflammatory bowel disease (IBD) are lifelong chronic diseases affecting the gastrointestinal tract. The precise etiology and the different actors participating to the...

Sponsor: University Hospital, LilleEnrolling: 1001 location
RECRUITINGNCT07314151

Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics...

This study will be conducted at the outpatient clinic of China Medical University hospital. It is expected to enroll two groups of 30 subjects, including the experimental group...

Sponsor: China Medical University HospitalEnrolling: 2001 location
RECRUITINGPhase 3NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to...

Sponsor: Eli Lilly and CompanyEnrolling: 9020 locations
RECRUITINGNCT04740541

Threonine Requirement in Adult Males With Crohn's Disease Using IAAO

The goal of the current study is to measure the requirement for threonine in patients with CD using the IAAO method and compare the requirement to previously determined threonine...

Sponsor: The Hospital for Sick ChildrenEnrolling: 101 location
RECRUITINGNCT06587646

VirtuAl Technology to Improve the Management of Perianal Crohn's (VAMP) - PROSPECTIVE

Crohn's is an inflammatory condition that can affect any part of the gut. Over half a million people in the UK live with Crohn's disease and about a quarter will develop a fistula...

Sponsor: Nottingham University Hospitals NHS TrustEnrolling: 301 location
RECRUITINGPhase 1 / Phase 2NCT04263831

Low Dose IL-2 for the Treatment of Crohn's Disease

The purpose of this study is to determine the safety and maximum effective dose (MED) of Interleukin-2 in subjects with moderate-to-severe crohn's disease.

Sponsor: Boston Children's HospitalEnrolling: 303 locations
RECRUITINGNCT06505304

AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease

This is a multicentre prospective international observational study. This study aims to introduce a novel multidimensional approach to precision imaging, enabling the...

Sponsor: University College CorkEnrolling: 22515 locations
RECRUITINGPhase 4NCT05906576

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Post-marketing registration of Infliximab for injection in Chinese pediatric Crohn's disease patients.

Sponsor: Taizhou Mabtech Pharmaceutical Co.,LtdEnrolling: 301 location
RECRUITINGPhase 2NCT01962415

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched...

Sponsor: Paul SzabolcsEnrolling: 1001 location
RECRUITINGPhase 3NCT04777656

Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric...

This research is a multicenter French randomized and single blinded phase III clinical trial evaluating two treatment strategies among Crohn's disease (CD) patients. The main...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1204 locations
RECRUITINGNCT04973423

STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL...

Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) that can dramatically affect the quality of life of patients. Due to its transmural nature (involvement of the...

Sponsor: University Hospital, Clermont-FerrandEnrolling: 18017 locations
RECRUITINGPhase 1 / Phase 2NCT06636032

Dose Escalation of Allogeneic Adipose Derived Stroma/Stem Cells for the Treatment of Crohn's Fistula

Perianal fistulas are in the forefront (42 to 72, 4%) of morbid complication of Crohn's disease, affecting nearly one- third of patients and complicating abscesses in 35-48% of...

Sponsor: University Hospital, ToulouseEnrolling: 91 location
RECRUITINGNCT07237516

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does...

Sponsor: University of North Carolina, Chapel HillEnrolling: 2005 locations
RECRUITINGNCT07305454

Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic...

Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies,...

Sponsor: University Hospital, ToulouseEnrolling: 711 location
RECRUITINGNCT04751396

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for...

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 1251 location
RECRUITINGNCT01277419

German Spondyloarthritis Inception Cohort

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA...

Sponsor: Charite University, Berlin, GermanyEnrolling: 10001 location

Showing 50 of 100 trials.Search all Perianal Crohns Disease trials

Frequently Asked Questions

There are currently 100 clinical trials for Perianal Crohns Disease, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Perianal Crohns Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 11 Phase 3 trials for Perianal Crohns Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.